In the News

101 News Items found
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
George Bosl
Announcement
Learn about George Bosl, who will become MSK's first ombudsperson.
Man with glasses holding a dental prosthetic and tools in his hands.
Feature
A vital part of MSK's mission is to get patients back to feeling like themselves.
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
In the Lab
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
Amy Speck
Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Steve and Sara Harrold smiling and holding hands on a couch in Hope Lodge
Learn how MSK Direct — one of the nation's largest employer cancer benefits programs — made it easier for Steve Harrold to travel from Massachusetts to MSK for treatment days after a throat cancer diagnosis.
Illustration of human neck and head with thyroid gland highlighted and tumor growing on gland.
Science Byte
MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.
Gloved hands holding a pipette.
Feature
This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
Dr. Debyani Chakravarty
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Tumor mutation model
Finding
Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.